Medical News

RSS

Five-stage reverse osmosis best for removal of hexavalent chromium from drinking water

The only way to learn if your water source has hexavalent chromium is to check with your public water supplier and request a water quality report, said NJIT Professor Taha Marhaba, a civil/environmental engineer. Most municipal or city engineers should be able to provide such a report upon request. Additional information specifically about hexavalent chromium levels may also be available.

24 Dec 2010

Quercetin and resveratrol may play an important role in inflammation and insulin resistance

A study was carried out to examine the extent to which quercetin and trans-resveratrol (RSV) prevented inflammation or insulin resistance in primary cultures of human adipocytes treated with tumor necrosis factor-a (TNF-a)-an inflammatory cytokine elevated in the plasma and adipose tissue of obese, diabetic individuals. Cultures of human adipocytes were pretreated with quercetin and trans-RSV followed by treatment with TNF-a. Subsequently, gene and protein markers of inflammation and insulin resistance were measured.

24 Dec 2010

China emerging as world leader in stem-cell R&D

Recent breakthroughs show that China is emerging as a world leader in stem-cell research and development, says Emerging Healthcare Solutions President and CEO Cindy Morrissey.

24 Dec 2010

Research Roundup: Surgery and health costs; ACOs and independent doctors; Stroke's long-term effects; Improving low-income care

Archives of Surgery: Profile Of Inpatient Operating Room Procedures In U.S. Hospitals In 2007 - Understanding operating room (OR) procedures in the hospital "is critical in debates about how to improve the population's health while attempting to constrain growth in health care costs," write the authors of this study that provides an overview of inpatient operating room procedures in the U.S. from 1997 to 2007.

24 Dec 2010

Molecular-level insights into how physical activity influences the heart

Everyone knows that exercise comes with metabolic and cardiovascular benefits, but scientists understand surprisingly little about how physical activity influences the heart itself. Now, a new study in the December 23rd issue of Cell, a Cell Press publication, offers some of the first molecular-level insights.

24 Dec 2010

Scientists tweak gene to mimick heart-strengthening effects of endurance training in sedentary mice

By tweaking a single gene, scientists have mimicked in sedentary mice the heart-strengthening effects of two weeks of endurance training, according to a report from Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center (BIDMC).

24 Dec 2010

Financial Times examines how Brazil's state-run drug sector is engaging in partnerships at home, abroad

"Dilma Rousseff had barely been confirmed as Brazil's new president in November when she made her first foreign visit, to Mozambique," which "included a symbolic stop-off at a pharmaceutical factory that is under construction in preparation for opening in 2014. … The plant will produce a range of medicines for one of its leading lusophone - Portuguese-speaking - African partners, marking the resurgent power and growing reach of its sponsor, Brazil's own state-led drug sector," the Financial Times writes in an article that examines the partnerships Brazil is establishing at home and abroad.

24 Dec 2010

Positron granted U.S. patents for quantum photodetectors

Positron Corporation, a leading molecular imaging company specializing in the field of nuclear cardiology, today announced it has received two U.S. patents for its proprietary quantum photodetectors.

24 Dec 2010

Sequestering GSK3 enzyme leads to stabilization of proteins in cells

The cell signaling pathway known as Wnt, commonly activated in cancers, causes internal membranes within a healthy cell to imprison an enzyme that is vital in degrading proteins, preventing the enzyme from doing its job and affecting the stability of many proteins within the cell, researchers at UCLA's Jonsson Comprehensive Cancer Center have found.

24 Dec 2010

RegeneRx common stock to be quoted on OTC Bulletin Board following NYSE Amex suspension

RegeneRx Biopharmaceuticals, Inc. announced today that beginning with the opening of trading on December 23, 2010, the Company's common stock is expected to be quoted on the OTC Bulletin Board under the symbol RGRX following its suspension from the NYSE Amex as of that date.

24 Dec 2010

Silencing of specific genes of germinal cell lines reduces brain tumors

Scientists at IRB Barcelona have discovered that some brain tumours in larvae of the fruit fly Drosophila melanogaster use the genetic programme of germline cells to grow. The removal of some of these genes leads to healthy brains. This finding demonstrates that these genes are crucial for tumour development. The study, headed by ICREA researcher Cayetano Gonz-lez, is published today in the prestigious journal Science.

24 Dec 2010

Scientific American examines efforts to increase influenza virus monitoring in pigs to prevent pandemics in humans

Scientific American examines how, in an attempt to improve early recognition of viruses that could give rise to pandemics in people, such as last year's H1N1 swine flu, scientists are looking to better understand "the viruses that infect the estimated 941 million domesticated pigs around the world." However, as the article notes, "[i]ntensive monitoring of pig viruses is unlikely to come any time soon … Most pork-producing countries do not test their pigs at all, and in some that do - such as the U.S. - the testing is done on behalf of the pork producers.

24 Dec 2010

Teva receives FDA complete response letter for glatiramer acetate 0.5mL injection sNDA

Teva Pharmaceutical Industries Ltd. announced today that it has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its supplemental New Drug Application (sNDA) for a lower-volume (0.5mL) injection of glatiramer acetate. Copaxone® containing 20mg of glatiramer acetate in 1ml is the global market leader in the treatment of relapsing-remitting multiple sclerosis (RRMS).

24 Dec 2010

YM Biosciences underwriters exercise Over-Allotment Option in full

YM BioSciences Inc. announced today that, in connection with its previously announced public offering for total net proceeds before expenses of US $37,650,000, the underwriters have exercised in full their Over-Allotment Option to purchase an additional 3,750,000 common shares of YM at US $1.60 per share for additional net proceeds of US $5,665,000.

24 Dec 2010

American Regent initiates voluntary recall of Sodium Bicarbonate Injection, USP 7.5% and 8.4%

American Regent is conducting a nationwide voluntary recall to the consumer and user level of ALL unexpired lots of the following products: Sodium Bicarbonate Injection, USP, 7.5%, 44.6 mEq/50 mL, Single Dose Vial

24 Dec 2010

Report examines infant, child feeding practices in 33 countries

A report (.pdf), released Wednesday, on breastfeeding practices in 33 countries found that out of 78 million infants born each year, about 42 million do not receive an optimal amount of breastfeeding, IANS/Sify News reports (12/22).

24 Dec 2010

Paternal diet affects lipid metabolizing genes in offspring

Scientists at the University of Massachusetts Medical School and the University of Texas at Austin have uncovered evidence that environmental influences experienced by a father can be passed down to the next generation, "reprogramming" how genes function in offspring. A new study published this week in Cell shows that environmental cues-in this case, diet-influence genes in mammals from one generation to the next, evidence that until now has been sparse.

24 Dec 2010

Alimera receives FDA CRL for ILUVIEN NDA

pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, including the investigational drug ILUVIEN® for the treatment of Diabetic Macular Edema (DME), today announced that Alimera Sciences, Inc, pSivida's collaborative partner, received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ILUVIEN. The FDA issued the CRL to communicate its decision that the NDA cannot be approved in its present form.

24 Dec 2010

9/11 responders health bill gains congressional nod

In one of the last acts of this not-so-lame lame-duck Congress, lawmakers overcame wrangling and cleared legislation that would cover the costs of medical care for 9/11 rescue workers.

24 Dec 2010

Texas doctor arrested in whistle-blowing case; Mass. judge dismisses hospital payment lawsuit against the state

Texas officials have filed criminal charges against a West Texas physician over accusations that they say he orchestrated against two nurses who had filed a complaint against him with the state medical board (Sack, 12/23).

24 Dec 2010

Medical News

Five-stage reverse osmosis best for removal of hexavalent chromium from drinking water

Quercetin and resveratrol may play an important role in inflammation and insulin resistance

China emerging as world leader in stem-cell R&D

Research Roundup: Surgery and health costs; ACOs and independent doctors; Stroke's long-term effects; Improving low-income care

Molecular-level insights into how physical activity influences the heart

Scientists tweak gene to mimick heart-strengthening effects of endurance training in sedentary mice

Financial Times examines how Brazil's state-run drug sector is engaging in partnerships at home, abroad

Positron granted U.S. patents for quantum photodetectors

Sequestering GSK3 enzyme leads to stabilization of proteins in cells

RegeneRx common stock to be quoted on OTC Bulletin Board following NYSE Amex suspension

Silencing of specific genes of germinal cell lines reduces brain tumors

Scientific American examines efforts to increase influenza virus monitoring in pigs to prevent pandemics in humans

Teva receives FDA complete response letter for glatiramer acetate 0.5mL injection sNDA

YM Biosciences underwriters exercise Over-Allotment Option in full

American Regent initiates voluntary recall of Sodium Bicarbonate Injection, USP 7.5% and 8.4%

Report examines infant, child feeding practices in 33 countries

Paternal diet affects lipid metabolizing genes in offspring

Alimera receives FDA CRL for ILUVIEN NDA

9/11 responders health bill gains congressional nod

Texas doctor arrested in whistle-blowing case; Mass. judge dismisses hospital payment lawsuit against the state

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News